ACME Archives - Mediformatica

This is a process evaluation of a large UK-based randomised controlled trial (RCT) (n = 5602) evaluating the effectiveness of recommending an alcohol reduction app, Drink Less, compared with usual digital care in reducing alcohol consumption…

Integrative molecular–radiopathomic characterization of AIRE-driven immune subtypes in bladder cancer

Texas AG sues Epic Systems

HIMSSCast: Should GPT-5 be HIPAA compliant, FDA regulated?

HIMSSCast: New book offers first-person look back on challenging early chapter for healthcare AI

Tag: ACME

Do engagement and behavioural mechanisms underpin the effectiveness of the Drink Less app?

Brightside Health Raises Strategic Series C, Welcomes Trip Hofer to Board of Directors | Healthcare IT Today

Integrative molecular–radiopathomic characterization of AIRE-driven immune subtypes in bladder cancer

Texas AG sues Epic Systems

HIMSSCast: Should GPT-5 be HIPAA compliant, FDA regulated?

HIMSSCast: New book offers first-person look back on challenging early chapter for healthcare AI

Healthcare AI implementation needs trust, training and teamwork

Evaluating the Quality and Features of Visual Acuity Apps Using the Mobile App Rating Scale: Systematic Review

Trump creates AI Task Force to oversee and challenge state regulation

Are we in a new era for EHRs?

Healthcare leaders reveal 2025’s biggest surprises, Part 1

Healthcare leaders reveal 2025’s biggest surprises, part one

MediFormatica

News Aggregator